Target Selectivity of AZD5363 (Capivasertib)
| Key Target | IC50 | Description | Reference |
|---|---|---|---|
| AKT1 | 3 nM | in vitro potency measurement | PMC12990551 |
| AKT3 | 3 nM | in vitro potency measurement | PMC12990551 |
| AKT2 | 9 nM | in vitro potency measurement | PMC12990551 |
| AKT isoforms | 10 nM | -- | PMC4658545 |
| AKT 1 | 10 nM | Enzyme inhibition assay | PMC5613074 |
| AKT 2 | 10 nM | Enzyme inhibition assay | PMC5613074 |
| AKT 3 | 10 nM | Enzyme inhibition assay | PMC5613074 |
Check the
AZD5363 (Capivasertib)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Jump to
- AZD5363 (Capivasertib) Mechanism of Action: AKT Inhibition in Breast Cancer Cells Research
- AZD5363 (Capivasertib) Clinical Trials
- AZD5363 (Capivasertib) Working Concentration | Cell Culture | Treatment
- AZD5363 (Capivasertib) Solubility in DMSO
- AZD5363 (Capivasertib) Stock Solution
- AZD5363 (Capivasertib) Storage
- AZD5363 (Capivasertib) Stability
- AZD5363 (Capivasertib) Combination Database
- AZD5363 (Capivasertib) Molecular Weight
- AZD5363 (Capivasertib) SMILES
- AZD5363 (Capivasertib) CAS Number
- AZD5363 (Capivasertib) Chemical Structure (2D and 3D)
- AZD5363 (Capivasertib) IC50 for Cell-based and Cell-free Assays
- AZD5363 (Capivasertib) Sigma (AMBH2D6FA35F)? Try a better option.
- AZD5363 (Capivasertib) MedChemExpress (HY-15431)? Try a better option.
- AZD5363 (Capivasertib) Cayman (15406)? Try a better option.
- AZD5363 (Capivasertib) Tocris (6978)? Try a better option.
- AZD5363 (Capivasertib) Abcam (ab282438)? Try a better option.
- AZD5363 (Capivasertib) SDS｜MSDS